{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T17:54:46Z","timestamp":1785779686459,"version":"3.56.0"},"reference-count":15,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,2,23]],"date-time":"2026-02-23T00:00:00Z","timestamp":1771804800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. National Institutes of Health","doi-asserted-by":"publisher","award":["R01-AI145435-A1"],"award-info":[{"award-number":["R01-AI145435-A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. National Institutes of Health","doi-asserted-by":"publisher","award":["R01-AI153349"],"award-info":[{"award-number":["R01-AI153349"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. National Institutes of Health","doi-asserted-by":"publisher","award":["R56-AI179012-A1"],"award-info":[{"award-number":["R56-AI179012-A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. National Institutes of Health","doi-asserted-by":"publisher","award":["R01-AI190038"],"award-info":[{"award-number":["R01-AI190038"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. National Institutes of Health","doi-asserted-by":"publisher","award":["S10-OD030381-A1"],"award-info":[{"award-number":["S10-OD030381-A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,8,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Tuberculous meningitis causes substantial mortality due to limited penetration of antibiotics to the central nervous system and excessive neuroinflammation. This study evaluated clofazimine as an adjunct to the standard first-line tuberculosis regimen, in a mouse model. Mice were infected intracerebrally with Mycobacterium tuberculosis and treated for 6 weeks. Addition of clofazimine markedly reduced the brain bacterial burden, achieving measurable brain tissue concentrations despite minimal cerebrospinal fluid penetration, as well as attenuated brain tissue inflammation. These findings indicate that clofazimine enhances bactericidal activity of the standard regimen and mitigate neuroinflammation, supporting further investigation and clinical evaluation for tuberculous meningitis.<\/jats:p>","DOI":"10.1093\/infdis\/jiag123","type":"journal-article","created":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T12:35:27Z","timestamp":1771677327000},"page":"e195-e199","source":"Crossref","is-referenced-by-count":0,"title":["Addition of Clofazimine Enhances the Activity of Standard Treatment Regimen in a Mouse Model of Tuberculous Meningitis"],"prefix":"10.1093","volume":"234","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1574-7759","authenticated-orcid":false,"given":"Xueyi","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland ,","place":["USA"]},{"name":"Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, Maryland ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4714-404X","authenticated-orcid":false,"given":"Carlos E","family":"Ruiz-Gonzalez","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio ,","place":["USA"]},{"name":"Cincinnati Children's Center for Molecular Imaging and Precision Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8333-7180","authenticated-orcid":false,"given":"Yuderleys","family":"Masias-Leon","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio ,","place":["USA"]},{"name":"Cincinnati Children's Center for Molecular Imaging and Precision Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9748-0554","authenticated-orcid":false,"given":"Medha","family":"Singh","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio ,","place":["USA"]},{"name":"Cincinnati Children's Center for Molecular Imaging and Precision Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9002-7052","authenticated-orcid":false,"given":"Charles A","family":"Peloquin","sequence":"additional","affiliation":[{"name":"Infectious Disease Pharmacokinetics Laboratory, Pharmacotherapy and Translational Research, University of Florida College of Pharmacy, Gainesville, Florida ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9620-7070","authenticated-orcid":false,"given":"Sanjay K","family":"Jain","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland ,","place":["USA"]},{"name":"Center for Tuberculosis Research, Johns Hopkins University School of Medicine, Baltimore, Maryland ,","place":["USA"]},{"name":"Department of Pediatrics, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio ,","place":["USA"]},{"name":"Cincinnati Children's Center for Molecular Imaging and Precision Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,2,23]]},"reference":[{"key":"2026080313223133700_jiag123-B1","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s41590-018-0119-x","article-title":"Tuberculous meningitis: a roadmap for advancing basic and translational research","volume":"19","author":"Jain","year":"2018","journal-title":"Nat Immunol"},{"key":"2026080313223133700_jiag123-B2","doi-asserted-by":"crossref","first-page":"3042","DOI":"10.1128\/AAC.00260-15","article-title":"Pharmacokinetics and pharmacodynamics of clofazimine in a mouse model of tuberculosis","volume":"59","author":"Swanson","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"key":"2026080313223133700_jiag123-B3","doi-asserted-by":"crossref","first-page":"e155851","DOI":"10.1172\/JCI155851","article-title":"High-dose rifampin improves bactericidal activity without increased intracerebral inflammation in animal models of tuberculous meningitis","volume":"132","author":"Ruiz-Bedoya","year":"2022","journal-title":"J Clin Invest"},{"key":"2026080313223133700_jiag123-B4","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1056\/NEJMoa2117166","article-title":"A 24-week, all-oral regimen for rifampin-resistant tuberculosis","volume":"387","author":"Nyang\u2019wa","year":"2022","journal-title":"N Engl J Med"},{"key":"2026080313223133700_jiag123-B5","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1093\/jac\/dkaf176","article-title":"Four-month clofazimine regimen for susceptible pulmonary TB: a randomized clinical trial","volume":"80","author":"Shafiq","year":"2025","journal-title":"J Antimicrob Chemother"},{"key":"2026080313223133700_jiag123-B6","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S1473-3099(25)00436-0","article-title":"A 3-month clofazimine-rifapentine-containing regimen for drug-susceptible tuberculosis versus standard of care (Clo-Fast): a randomised, open-label, phase 2c clinical trial","volume":"26","author":"Metcalfe","year":"2026","journal-title":"Lancet Infect Dis"},{"key":"2026080313223133700_jiag123-B7","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1093\/cid\/ciab992","article-title":"Cycloserine and linezolid for Tuberculosis meningitis: pharmacokinetic evidence of potential usefulness","volume":"75","author":"Kempker","year":"2022","journal-title":"Clin Infect Dis"},{"key":"2026080313223133700_jiag123-B8","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10735-015-9634-3","article-title":"Evidence for the presence of clofazimine and its distribution in the healthy mouse brain","volume":"46","author":"Baijnath","year":"2015","journal-title":"J Mol Histol"},{"key":"2026080313223133700_jiag123-B9","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0190-9622(95)90134-5","article-title":"Clofazimine: a review of its medical uses and mechanisms of action","volume":"32","author":"Arbiser","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"2026080313223133700_jiag123-B10","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.3390\/jcm11071927","article-title":"Investigation of clofazimine resistance and genetic mutations in drug-resistant Mycobacterium Tuberculosis isolates","volume":"11","author":"Park","year":"2022","journal-title":"J Clin Med"},{"key":"2026080313223133700_jiag123-B11","doi-asserted-by":"crossref","first-page":"e0093125","DOI":"10.1128\/aac.00931-25","article-title":"Cerebrospinal fluid penetration of cycloserine\/terizidone and clofazimine in patients with pulmonary TB","volume":"69","author":"Upton","year":"2025","journal-title":"Antimicrob Agents Chemother"},{"key":"2026080313223133700_jiag123-B12","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1128\/AAC.01731-12","article-title":"Multiscale distribution and bioaccumulation analysis of clofazimine reveals a massive immune system-mediated xenobiotic sequestration response","volume":"57","author":"Baik","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"key":"2026080313223133700_jiag123-B13","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.it.2020.07.007","article-title":"The role of astrocytes in CNS inflammation","volume":"41","author":"Giovannoni","year":"2020","journal-title":"Trends Immunol"},{"key":"2026080313223133700_jiag123-B14","doi-asserted-by":"crossref","first-page":"e0025424","DOI":"10.1128\/msphere.00254-24","article-title":"Clofazimine inhibits innate immunity against Mycobacterium tuberculosis by NF-kappaB","volume":"9","author":"Li","year":"2024","journal-title":"mSphere"},{"key":"2026080313223133700_jiag123-B15","doi-asserted-by":"crossref","first-page":"115539","DOI":"10.1016\/j.biopha.2023.115539","article-title":"Clofazimine: a journey of a drug","volume":"167","author":"Xu","year":"2023","journal-title":"Biomed Pharmacother"}],"container-title":["The Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jid\/advance-article-pdf\/doi\/10.1093\/infdis\/jiag123\/67077243\/jiag123.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/234\/1\/e195\/67077243\/jiag123.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jid\/article-pdf\/234\/1\/e195\/67077243\/jiag123.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T17:22:39Z","timestamp":1785777759000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jid\/article\/234\/1\/e195\/8495098"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,23]]},"references-count":15,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,2,23]]},"published-print":{"date-parts":[[2026,8,3]]}},"URL":"https:\/\/doi.org\/10.1093\/infdis\/jiag123","relation":{},"ISSN":["0022-1899","1537-6613"],"issn-type":[{"value":"0022-1899","type":"print"},{"value":"1537-6613","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,7,15]]},"published":{"date-parts":[[2026,2,23]]}}}